top of page
Executive Spotlights

Haemonetics to acquire OpSens for more than $250M

Boston, MA, October 10, 2023 (PRNewswire) -- Haemonetics (NYSE: HAE) has announced an agreement for the acquisition of OpSens, a technology company specializing in cardiology. Based in Boston, Haemonetics will purchase all the outstanding shares of OpSens at a price of CAD $2.90 per share in an all-cash deal. The transaction is anticipated to be completed by the end of January 2024.


Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial

Commentaires


Life Science Headlines
bottom of page